Dexchlorpheniramine maleate and Remicade drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Dexchlorpheniramine maleate (dexchlorpheniramine maleate) and Remicade (infliximab). Common drug interactions include infusion related reaction among females and infusion related reaction among males.
The phase IV clinical study analyzes what interactions people have when they take Dexchlorpheniramine maleate and Remicade. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.
What is Dexchlorpheniramine maleate?
Dexchlorpheniramine maleate has active ingredients of dexchlorpheniramine maleate. eHealthMe is studying from 1,509 Dexchlorpheniramine maleate users. Check the latest studies of Dexchlorpheniramine maleate.
What is Remicade?
Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.
28 people who take Dexchlorpheniramine maleate and Remicade together, and have interactions are studied.

What are the common drug interactions of Dexchlorpheniramine Maleate and Remicade, by gender? *:
female:
- Infusion related reaction
- Angiopathy (generic term for a disease of the blood vessels)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Gastroenteritis (inflammation of stomach and intestine)
- Malaise (a feeling of general discomfort or uneasiness)
- Upper respiratory tract inflammation
- Anaphylactic reaction (serious allergic reaction)
- Haemorrhage (bleeding)
- Headache (pain in head)
- Hypersensitivity
male:
- Infusion related reaction
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Oropharyngeal pain
- Prostatic disorder
- Sputum increased
- Swollen tongue (swelling of tongue)
- Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
- Therapeutic response decreased (less preventive response)
- Blood pressure increased
- Chest discomfort
What are the common drug interactions of Dexchlorpheniramine Maleate and Remicade, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Anaphylactic reaction (serious allergic reaction)
- Haemorrhage (bleeding)
- Headache (pain in head)
- Hypersensitivity
- Malaise (a feeling of general discomfort or uneasiness)
- Pain
- Proctalgia (pain in the rectum)
- Rectal discharge (discharge from rectum)
- Weight decreased
- Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
20-29:
- Infusion related reaction
- Angiopathy (generic term for a disease of the blood vessels)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Gastroenteritis (inflammation of stomach and intestine)
- Upper respiratory tract inflammation
- Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
- Hot flush (sudden feelings of heat)
- Hypotension (abnormally low blood pressure)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Adams-stokes syndrome (sudden attacks of unconsciousness)
30-39:
- Infusion related reaction
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Antinuclear antibody increased
- Blood creatine phosphokinase increased
- Cataract (clouding of the lens inside the eye)
- Cytomegalovirus infection
- Dna antibody positive
- Gingivitis (inflammation of gums)
- Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
- Therapeutic response decreased (less preventive response)
40-49:
- Herpes zoster
- Chest pain
- Infusion related reaction
- Muscle spasms (muscle contraction)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
50-59:
- Blood pressure increased
- Chest discomfort
- Erythema (redness of the skin)
- Hot flush (sudden feelings of heat)
- Infusion related reaction
- Malaise (a feeling of general discomfort or uneasiness)
- Rash
- Dyspnoea (difficult or laboured respiration)
- Herpes zoster
- Hypoxia (low oxygen in tissues)
60+:
- Dyspnoea (difficult or laboured respiration)
- Infusion related reaction
- Prostatic disorder
- Sputum increased
- Swollen tongue (swelling of tongue)
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Coronary artery thrombosis (clot formation in coronary artery)
- Coronary artery atherosclerosis (life-threatening blockages in the arteries of your heart)
- Flushing (the warm, red condition of human skin)
What are the existing conditions these people have? *
- Behcet's Syndrome (involves inflammation of the blood vessels): 9 people, 32.14%
- Sinusitis (inflammation of sinus): 6 people, 21.43%
- Keratitis (eye's cornea, the front part of the eye, becomes inflamed): 6 people, 21.43%
- Glaucoma (increased fluid pressure in the eye with vision loss): 6 people, 21.43%
- Gastritis (inflammation of stomach): 6 people, 21.43%
- Upper Respiratory Tract Inflammation: 3 people, 10.71%
- Ingrowing Nail: 3 people, 10.71%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 10.71%
- Seasonal Allergy (allergic condition due to certain season): 2 people, 7.14%
- Pharyngitis (inflammation of the pharynx, causing a sore throat): 2 people, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Dexchlorpheniramine maleate and Remicade?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Dexchlorpheniramine maleate (1,509 reports)
- Remicade (224,011 reports)
Browse all drug interactions of Dexchlorpheniramine maleate and Remicade:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Dexchlorpheniramine maleate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Remicade:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dexchlorpheniramine maleate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Remicade and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on dexchlorpheniramine maleate and infliximab (the active ingredients of Dexchlorpheniramine maleate and Remicade, respectively), and Dexchlorpheniramine maleate and Remicade (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Kaletra cause Acne? - a second ago
- Drug interactions of Digoxin and Didanosine - 2 seconds ago
- Beclovent vs. Theophylline, side effect and effectiveness comparison - 9 seconds ago
- Could Crestor cause Appetite Disorder? - 14 seconds ago
- Drug interactions of Nystop and Reglan - 18 seconds ago
- Could Sodium Bicarbonate cause Blood Sodium Decreased? - 18 seconds ago
- Drug interactions of Janumet and Benadryl - 19 seconds ago
- Could Bactroban cause Peritonitis? - 21 seconds ago
- Could Metoprolol Succinate cause Diplopia? - 30 seconds ago
- Could Prialt cause Diplopia? - 35 seconds ago